Loading clinical trials...
Loading clinical trials...
Anti-vascular endothelial growth factor (VEGF) therapy is currently the mainstay of treatment for diabetic macular edema (DME). One of the main obstacles of anti-VEGF therapy is the need of repeated i...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Cairo University
NCT07296952 · Diabetic Retinopathy (DR)
NCT07351786 · Diabetes (DM), Retinopathy, Diabetic, and more
NCT03713268 · Macular Holes, Epiretinal Membrane, and more
NCT03135327 · Multiple Sclerosis, Dry Eye Syndromes, and more
NCT06782997 · Diabetic Retinopathy
Faculty of Medicine, Cairo University
Cairo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions